Public Health officials awaiting evidence on AstraZeneca blood clot concerns

Public Health officials awaiting evidence on AstraZeneca blood clot concerns

Chair of the National Immunisation Advisory Committee, Professor Karina Butler. Picture: Colin Keegan, Collins Dublin

Use of the AstraZeneca Covid-19 vaccine here will only resume once public health officials are satisfied that the blood-clotting issues surrounding it are coincidental.

Speaking at this evening’s public health briefing, Chair of the National Immunisation Advisory Committee, Professor Karina Butler said that all vaccines authorised for use in Ireland were "proven to be very effective against severe Covid-19 disease."

Already a subscriber? Sign in

You have reached your article limit.

Unlimited access. Half the price.

Annual €130 €65

Best value

Monthly €12€6 / month

More in this section

Lunchtime News

Newsletter

Keep up with stories of the day with our lunchtime news wrap and important breaking news alerts.

Cookie Policy Privacy Policy Brand Safety FAQ Help Contact Us Terms and Conditions

© Examiner Echo Group Limited